The SPDR S&P Biotech ETF (XBI) provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap.
For XBI Options Trading, they trade with only Friday expirations priced in increments of $0.50. and are a very popular, low priced play which can often provide weekly gains of over 5,000%.
2020 Range: (62.94 – 152.70)
2020 Close: 140.78
Get this week and next week’s XBI Options Trade Forecast view by clicking here
Weekly Chart
Daily Chart
5 Day Chart
Get the XBI Monthly and LEAP Options Trade Forecast view by clicking here
Pivot Points
(updated weekly after Friday’s close)
| Support/Resistance Levels | Price | Key Turning Points |
|---|---|---|
| 52-Week High | 174.79 | |
| 14 Day RSI at 80% | 171.67 | |
| 14 Day RSI at 70% | 149.54 | |
| 146.46 | 38.2% Retracement From 52 Week High | |
| 13-Week High | 141.50 | |
| 1-Month High | 141.50 | |
| 137.71 | 50% Retracement From 52 Week High/Low | |
| 134.69 | 38.2% Retracement From 4 Week High | |
| 132.61 | 38.2% Retracement From 13 Week High | |
| 132.58 | 50% Retracement From 4 Week High/Low | |
| 131.84 | 14 Day RSI at 50% | |
| 130.48 | 38.2% Retracement From 4 Week Low | |
| 129.87 | 50% Retracement From 13 Week High/Low | |
| 128.97 | 38.2% Retracement From 52 Week Low | |
| 127.12 | 38.2% Retracement From 13 Week Low | |
| Last | 125.94 | Last |
| 1-Month Low | 123.67 | |
| 14 Day RSI at 30% | 121.99 | |
| 13-Week Low | 118.23 | |
| 14 Day RSI at 20% | 109.69 | |
| 52-Week Low | 100.64 |
